Neuropathy > Lifestyle Options

Health Condition

Neuropathy

Healthy Lifestyle Tips

Neuropathy is a common complication of chronic diabetes, but careful regulation of blood glucose levels can help reduce the risk and slow the progression of diabetic neuropathy.40,41 Exercise interventions have been shown to improve peripheral nerve function and reduce neuropathy symptoms in people with diabetes.42,43 In addition to promoting healthy blood glucose regulation, exercise can help preserve muscle mass and strength, which have been correlated with reduced risk and severity of diabetic neuropathy.44,42

While many people with type 1 diabetes can benefit from regular, moderate exercise, physical activity can lead to low blood sugar levels (hypoglycemia). If you have type 1 diabetes, never begin an intensive exercise program without consulting a healthcare professional first.

Some physical activities are not safe for people with neuropathy. These activities may cause injury or tissue damage that people with existing neuropathy may not feel or notice. This can lead to more serious problems. Consult with a qualified healthcare provider, such as a diabetes clinical exercise expert for guidance.

Because people with diabetic neuropathy have a high risk of foot complications, it is important to wear activity-appropriate, well-fitting footwear, and comfortable, moisture-wicking socks. Keeping feet clean and dry by carefully washing and drying between the toes will help protect foot health. It is also important to monitor the condition of the feet regularly, and notify a healthcare provider if calluses, blisters, or red, swollen, or inflamed areas that do not heal are present. Ask a spouse, partner, or home healthcare provider to help you with areas you can’t see, such as the bottoms of your feet.46,47

People with diabetes who smoke are at higher risk for diabetes complications, including neuropathy.48 Therefore, smoking cessation is an urgent goal for people with type 1 and type 2 diabetes to prevent diabetes-related neuropathy and foot disease.49

References

1. Yang H, Sloan G, Ye Y, et al. New Perspective in Diabetic Neuropathy: From the Periphery to the Brain, a Call for Early Detection, and Precision Medicine. Front Endocrinol (Lausanne) 2019;10:929.

2. Zajaczkowska R, Kocot-Kepska M, Leppert W, et al. Mechanisms of Chemotherapy-Induced Peripheral Neuropathy. Int J Mol Sci 2019;20.

3. Steps to Prevent or Delay Nerve Damage. American Diabetes Association [cited 2013 Nov 17]. Available from URL: www.diabetes.org/living-with-diabetes/complications/neuropathy/steps-to-prevent-or-delay.html.

4. Peripheral Neuropathy Fact Sheet. National Institute of Neurological Disorders and Stroke [cited 2013 Nov 17]. Available from URL: www.ninds.nih.gov/disorders/peripheralneuropathy/detail_peripheralneuropathy.htm.

5. Di Stefano G, Di Lionardo A, Galosi E, et al. Acetyl-L-carnitine in painful peripheral neuropathy: a systematic review. J Pain Res 2019;12:1341–51.

6. Dinicola S, Fuso A, Cucina A, et al. Natural products - alpha-lipoic acid and acetyl-L-carnitine - in the treatment of chemotherapy-induced peripheral neuropathy. Eur Rev Med Pharmacol Sci 2018;22:4739–54.

7. Sun Y, Shu Y, Liu B, et al. A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy. Exp Ther Med 2016;12:4017–24.

8. Hershman D, Unger J, Crew K, et al. Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L-Carnitine (SWOG S0715). J Natl Cancer Inst 2018;110:669–76.

9. Zhang Q, Ji L, Zheng H, et al. Low serum phosphate and magnesium levels are associated with peripheral neuropathy in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 2018;146:1–7.

10. Zhang Y, Li Q, Xin Y, et al. Association between serum magnesium and common complications of diabetes mellitus. Technol Health Care 2018;26:379–87.

11. Joy S, George T, Siddiqui K. Low magnesium level as an indicator of poor glycemic control in type 2 diabetic patients with complications. Diabetes Metab Syndr 2019;13:1303–7.

12. De Leeuw I, Engelen W, De Block C, Van Gaal L. Long term magnesium supplementation influences favourably the natural evolution of neuropathy in Mg-depleted type 1 diabetic patients (T1dm). Magnes Res 2004;17:109–14.

13. Wesselink E, Winkels R, van Baar H, et al. Dietary Intake of Magnesium or Calcium and Chemotherapy-Induced Peripheral Neuropathy in Colorectal Cancer Patients. Nutrients 2018;10.

14. Jordan B, Jahn F, Beckmann J, et al. Calcium and Magnesium Infusions for the Prevention of Oxaliplatin-Induced Peripheral Neurotoxicity: A Systematic Review. Oncology 2016;90:299–306.

15. Zhang M, Han W, Hu S, Xu H. Methylcobalamin: a potential vitamin of pain killer. Neural Plast 2013;2013:424651.

16. Solomon L. Vitamin B12-responsive neuropathies: A case series. Nutr Neurosci 2016;19:162–8.

17. Shibuya K, Misawa S, Nasu S, et al. Safety and efficacy of intravenous ultra-high dose methylcobalamin treatment for peripheral neuropathy: a phase I/II open label clinical trial. Intern Med 2014;53:1927–31.

18. Franques J, Chiche L, De Paula A, et al. Characteristics of patients with vitamin B12-responsive neuropathy: a case series with systematic repeated electrophysiological assessment. Neurol Res 2019;41:569–76.

19. Tavares Bello C, Capitao R, Sequeira Duarte J, et al. Vitamin B12 Deficiency in Type 2 Diabetes Mellitus. Acta Med Port 2017;30:719–26.

20. Gupta K, Jain A, Rohatgi A. An observational study of vitamin b12 levels and peripheral neuropathy profile in patients of diabetes mellitus on metformin therapy. Diabetes Metab Syndr 2018;12:51–8.

21. Roy R, Ghosh K, Ghosh M, et al. Study of Vitamin B12 deficiency and peripheral neuropathy in metformin-treated early Type 2 diabetes mellitus. Indian J Endocrinol Metab 2016;20:631–7.

22. Biemans E, Hart H, Rutten G, et al. Cobalamin status and its relationship with depression, cognition and neuropathy in patients with type 2 diabetes mellitus using metformin. Acta Diabetol 2015;52:383–93.

23. Wang D, Zhai J, Liu D. Serum folate, vitamin B12 levels and diabetic peripheral neuropathy in type 2 diabetes: A meta-analysis. Mol Cell Endocrinol 2017;443:72–9.

24. Russo G, Giandalia A, Romeo E, et al. Diabetic neuropathy is not associated with homocysteine, folate, vitamin B12 levels, and MTHFR C677T mutation in type 2 diabetic outpatients taking metformin. J Endocrinol Invest 2016;39:305–14.

25. Trippe B, Barrentine L, Curole M, Tipa E. Nutritional management of patients with diabetic peripheral neuropathy with L-methylfolate-methylcobalamin-pyridoxal-5-phosphate: results of a real-world patient experience trial. Curr Med Res Opin 2016;32:219–27.

26. Jacobs A, Cheng D. Management of diabetic small-fiber neuropathy with combination L-methylfolate, methylcobalamin, and pyridoxal 5'-phosphate. Rev Neurol Dis 2011;8:39–47.

27. Walker M, Morris L, Cheng D. Improvement of cutaneous sensitivity in diabetic peripheral neuropathy with combination L-methylfolate, methylcobalamin, and pyridoxal 5'-phosphate. Rev Neurol Dis 2010;7:132–9.

28. Talaei A, Siavash M, Majidi H, Chehrei A. Vitamin B12 may be more effective than nortriptyline in improving painful diabetic neuropathy. Int J Food Sci Nutr 2009;60:71–6.

29. Xu Q, Pan J, Yu J, et al. Meta-analysis of methylcobalamin alone and in combination with lipoic acid in patients with diabetic peripheral neuropathy. Diabetes Res Clin Pract 2013;101:99–105.

30. Schloss J, Colosimo M. B Vitamin Complex and Chemotherapy-Induced Peripheral Neuropathy. Curr Oncol Rep 2017;19:76.

31. Schloss J, Colosimo M, Airey C, et al. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN). Support Care Cancer 2017;25:195–204.

32. Senyigit A. The association between 25-hydroxy vitamin D deficiency and diabetic complications in patients with type 2 diabetes mellitus. Diabetes Metab Syndr 2019;13:1381–6.

33. Zhang B, Zhao W, Tu J, et al. The relationship between serum 25-hydroxyvitamin D concentration and type 2 diabetic peripheral neuropathy: A systematic review and a meta-analysis. Medicine (Baltimore) 2019;98:e18118.

34. Yammine K, Hayek F, Assi C. Is there an association between vitamin D and diabetic foot disease? A meta-analysis. Wound Repair Regen 2020;28:90–6.

35. Shehab D, Al-Jarallah K, Abdella N, et al. Prospective evaluation of the effect of short-term oral vitamin d supplementation on peripheral neuropathy in type 2 diabetes mellitus. Med Princ Pract 2015;24:250–6.

36. Alam U, Fawwad A, Shaheen F, et al. Improvement in Neuropathy Specific Quality of Life in Patients with Diabetes after Vitamin D Supplementation. J Diabetes Res 2017;2017:7928083.

37. Yammine K, Wehbe R, Assi C. A systematic review on the efficacy of vitamin D supplementation on diabetic peripheral neuropathy. Clin Nutr 2020.

38. Grim J, Ticha A, Hyspler R, et al. Selected Risk Nutritional Factors for Chemotherapy-Induced Polyneuropathy. Nutrients 2017;9.

39. Wang J, Udd K, Vidisheva A, et al. Low serum vitamin D occurs commonly among multiple myeloma patients treated with bortezomib and/or thalidomide and is associated with severe neuropathy. Support Care Cancer 2016;24:3105–10.

40. Hicks C, Selvin E. Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes. Curr Diab Rep 2019;19:86.

41. Iqbal Z, Azmi S, Yadav R, et al. Diabetic Peripheral Neuropathy: Epidemiology, Diagnosis, and Pharmacotherapy. Clin Ther 2018;40:828–49.

42. Parasoglou P, Rao S, Slade J. Declining Skeletal Muscle Function in Diabetic Peripheral Neuropathy. Clin Ther 2017;39:1085–103.

43. Mirtha L, Permatahati V. The Effectiveness of Aerobic Exercise in Improving Peripheral Nerve Functions in Type 2 Diabetes Mellitus: An Evidence Based Case Report. Acta Med Indones 2018;50:82–7.

44. Nomura T, Kawae T, Kataoka H, Ikeda Y. Aging, physical activity, and diabetic complications related to loss of muscle strength in patients with type 2 diabetes. Phys Ther Res 2018;21:33–8.

45. Ahmad Sharoni S, Minhat H, Mohd Zulkefli N, Baharom A. Health education programmes to improve foot self-care practices and foot problems among older people with diabetes: a systematic review. Int J Older People Nurs 2016;11:214–39.

46. Barshes N, Sigireddi M, Wrobel J, et al. The system of care for the diabetic foot: objectives, outcomes, and opportunities. Diabet Foot Ankle 2013;4.

47. Grisold A, Callaghan B, Feldman E. Mediators of diabetic neuropathy: is hyperglycemia the only culprit? Curr Opin Endocrinol Diabetes Obes 2017;24:103–11.

48. Xia N, Morteza A, Yang F, et al. Review of the role of cigarette smoking in diabetic foot. J Diabetes Investig 2019;10:202–15.